SuperworthOrchestra BioMed shares outstanding OBIO
Diluted shares outstanding, averaged over each quarter, from 2020.
- Latest quarter, to Jun 30, 2026
- 63.8M
- On a year earlier
- +66.2%
- more shares
Orchestra BioMed had 63.8M diluted shares outstanding on average in Q2 FY26, the quarter to Jun 30, 2026.
That is 66.2% more than a year earlier, so each share owns a little less of the company.
Shares outstanding over time
Fiscal year by fiscal year
| Fiscal year | Shares, fourth quarter | Change |
|---|---|---|
| FY2025 | 61.8M | +62% |
| FY2024 | 38.1M | +8% |
| FY2023 | 35.1M | +74% |
| FY2022 | 20.2M | −1% |
| FY2021 | 20.4M | n/a |
Each fiscal year is the twelve months to its fourth quarter, shown as the fourth quarter's average share count.
Quarter by quarter
| Quarter | Ended | Shares outstanding | On a year earlier |
|---|---|---|---|
| Q2 FY26 | 63.8M | +66% | |
| Q1 FY26 | 62.7M | +64% | |
| Q4 FY25 | 61.8M | +62% | |
| Q3 FY25 | 52.2M | +39% | |
| Q2 FY25 | 38.4M | +7% | |
| Q1 FY25 | 38.2M | +7% | |
| Q4 FY24 | 38.1M | +8% | |
| Q3 FY24 | 37.6M | +7% | |
| Q2 FY24 | 35.8M | +3% | |
| Q1 FY24 | 35.8M | +29% | |
| Q4 FY23 | 35.1M | +74% | |
| Q3 FY23 | 35.2M | +75% |
What the shares outstanding tells you
Diluted shares outstanding, averaged over the period. Fewer shares means each one owns more of the company.
A falling count usually means buybacks. A rising one means stock pay, acquisitions paid in shares or new shares sold.
More on Orchestra BioMed
Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.